Grifols’ Biotest to achieve USD 1 billion in US sales of Yimmugo® over next seven years
Biotest, a Grifols Group company, is expected to launch its recently FDA-approved intravenous immunoglobulin in the U.S. in first quarter […]
Shattuck Labs Announces Addition to Russell 2000® and Russell 3000® Indexes
AUSTIN, TX & DURHAM, NC, July 01, 2024 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck) (Nasdaq: STTK), a clinical-stage biotechnology […]
Fennec Pharmaceuticals Announces Management Change
RESEARCH TRIANGLE PARK, N.C., July 01, 2024 (GLOBE NEWSWIRE) — Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage […]
FAT Brands Announces Jordan Chirico as Executive Vice President and Head of Debt Capital Markets
Experienced Financial Executive Joins Fast-Growing Global Franchising Company LOS ANGELES, July 01, 2024 (GLOBE NEWSWIRE) — FAT (Fresh. Authentic. Tasty.) […]
Ragnarok Online Officially Launched in China on June 28, 2024
Seoul, South Korea, July 01, 2024 (GLOBE NEWSWIRE) — GRAVITY Co., Ltd. (NasdaqGM: GRVY) (“Gravity” or “Company”), a developer and […]
Alvotech Announces Record Preliminary Results for Revenues and EBITDA for the Second Quarter of 2024
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today […]
Li Auto Inc. June 2024 Delivery Update
BEIJING, China, July 01, 2024 (GLOBE NEWSWIRE) — Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), […]
Sportradar Secures Major Client Wins on Strength of Managed Trading Services
Sportradar’s Managed Trading Services See Significant Global Adoption in H1 2024 Notable client wins in South America and Africa highlight […]
Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA
Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA Mont-Saint-Guibert (Belgium), July 1, 2024, […]
Mesoblast to File Biologics License Application for Ryoncil® FDA Approval Next Week
NEW YORK, July 01, 2024 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory […]
